ClinicalTrials.gg
Enrolling by invitationNCT07543133Updated Nov 17, 2026

Simulation-Based Childbirth Training and Midwives' Outcomes

An interventional study of Simulation-Based Childbirth Management Training in Education and Maternal Health, sponsored by Selcuk University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2026, registered Apr 2026).
Updated Nov 17, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This randomized controlled study aims to evaluate the effect of simulation-based childbirth management training on safe motherhood practices and intrinsic motivation among midwives. Participants will be randomly assigned to either an intervention group receiving simulation-based training or a control group receiving no additional training. Outcomes will be assessed using validated scales before and after the intervention.

Read the detailed description

Simulation-based training is an effective educational approach that allows healthcare professionals to develop clinical skills in a safe and controlled environment. This study aims to evaluate the effectiveness of simulation-based childbirth management training on safe motherhood practices and intrinsic motivation among midwives.

The study is designed as a randomized controlled trial with a pre-test and post-test design. A total of 132 midwives will be included and randomly assigned to intervention and control groups. The intervention group will receive a structured simulation-based training program over five days, including obstetric scenarios such as normal delivery, postpartum hemorrhage, shoulder dystocia, and other obstetric emergencies. Each session will include pre-briefing, simulation practice, and debriefing.

The control group will continue routine practices without any additional intervention. Data will be collected using a Personal Information Form, Safe Motherhood Scale (for healthcare professionals), and Intrinsic Motivation Scale. Outcomes will be measured before and after the intervention.

The study aims to contribute to evidence-based midwifery education by evaluating both clinical practice outcomes and motivational factors.

02

Conditions studied

  • Education
  • Maternal Health

Keywords

  • Simulation-based training
  • Midwives
  • Safe motherhood
  • Intrinsic motivation
  • Randomized controlled trial
  • Obstetric simulation
03

In context

Lead sponsor

Selcuk University is the lead sponsor of 261 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Midwives working in healthcare institutions affiliated with the provincial health directorate
  • Having 5 years or less professional experience
  • Actively involved in prenatal, intrapartum, or postpartum care
  • Voluntary participation with written

Exclusion criteria

Exclusion Criteria:

  • Working in administrative positions
  • Previously received simulation-based childbirth or advanced obstetric simulation training
  • Inability to attend the full training program or complete data collection
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Simulation-Based Training Group

    Participants will receive simulation-based childbirth management training for five consecutive days (8 hours per day), including structured obstetric scenarios and debriefing sessions.

    Behavioral: Simulation-Based Childbirth Management Training

  • No intervention
    Control

    Participants will continue their routine clinical practice without receiving any additional training during the study period.

Interventions

  • BehavioralSimulation-Based Childbirth Management Training

    Participants will receive simulation-based childbirth management training for five consecutive days (8 hours per day), including structured obstetric scenarios and debriefing sessions.

06

What researchers measure

Primary outcomes

  1. Safe Motherhood Practices Level

    Measured using the Safe MotherhoodScale for Healthcare Professionals before and after the intervention. Assessed using the Safe Motherhood Scale for Healthcare Professionals, a 22-item Likert-type scale evaluating practices related to maternal and newborn safety. Higher scores indicate better safe motherhood practices.Possible score range: 22-110.

    Time frame: Before training and immediately after training (Day 5)

  2. Intrinsic Motivation Level

    Measured using the Intrinsic Motivation Scale before and after the intervention.Assessed using the Intrinsic Motivation Scale, a 21-item Likert-type scale measuring employees' intrinsic motivation across multiple dimensions. Higher scores indicate higher intrinsic motivation. Possible score range: 22-110.

    Time frame: Before training and immediately after training (Day 5)

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jan 2026 (actual). Primary completion is estimated for Mar 2027, 14 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Mar 2026 → Mar 2027 and completion Jun 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2026
First posted
Apr 21, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Mar 1, 2027was Mar 2026
CompletionEst.
Jun 1, 2027was Jun 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 1, 2026→Mar 1, 2027
Nov 17, 2026
Study completion
Jun 1, 2026→Jun 1, 2027
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Primary completion Mar 1, 2026→Mar 1, 2027
    Study completion Jun 1, 2026→Jun 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07543133
Lead sponsor
Selcuk University
Responsible party
Yasemin ERKAL AKSOY (Assoc. Prof., Selcuk University) — Principal investigator
First posted
Apr 21, 2026
Start date
Jan 1, 2026
Primary completion
Mar 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion